{
    "doi": "https://doi.org/10.1182/blood.V120.21.2657.2657",
    "article_title": "Constant Activation of the RAF-MEK-ERK Pathway As a Diagnostic and Therapeutic Target in Hairy Cell Leukemia. ",
    "article_date": "November 16, 2012",
    "session_type": "622. Non-Hodgkin Lymphoma - Biology, excluding Therapy: Poster II",
    "abstract_text": "Abstract 2657 The BRAF-V600E mutation defines genetically hairy cell leukemia (HCL) among B-cell leukemias and lymhphomas. In solid tumors, BRAF-V600E is known to aberrantly activate the oncogenic MEK-ERK pathway, and targeted BRAF and/or MEK inhibitors have shown remarkable efficacy in clinical trials of melanoma patients. However, the MEK-ERK pathway status in HCL has not been thoroughly investigated so far. Therefore, as a read-out of MEK-ERK pathway activation, we assessed phospho-ERK expression in 37 HCL patients using immunohistochemistry on routine biopsies and/or Western blotting on purified leukemic cells. Beside confirming the constant presence of BRAF-V600E in all patients, we documented ubiquitous phospho-ERK expression in HCL. Conversely, all 44 HCL-like cases in parallel studied (40 splenic marginal zone lymphoma, 2 HCL-variant and 2 splenic lymphoma/leukemia unclassifiable) were devoid of BRAF-V600E and none expressed phospho-ERK. Lack of phospho-ERK expression was also documented in two exceptionally rare cases of non-HCL CD5-negative B-cell lymphoproliferative disorders not otherwise specifiable that were previously described to harbour the BRAF-V600E mutation on allele-specific PCR (Arcaini et al, Blood 2012;119:188\u2013191), pointing to the presence of this mutation in only a small part of the leukemic clone in these cases. Our findings support the use of phospho-ERK immunohistochemistry in the differential diagnosis between HCL and HCL-like neoplasms and establish the MEK-ERK pathway as a rational therapeutic target in HCL. Disclosures: Tiacci: Not applicable: Dr. Tiacci filed a patent for the clinical use of BRAF mutations as biomarkers of HCL. Other. Inghirami: OncoEthix SA: Research Funding. Falini: Not applicable: Dr. Falini filed a patent for the clinical use of BRAF mutations as biomarkers of HCL. Other.",
    "topics": [
        "hairy-cell leukemia",
        "biological markers",
        "biopsy",
        "chronic lymphocytic leukemia",
        "leukemia",
        "leukemic cells",
        "lymphoproliferative disorders",
        "melanoma",
        "mitogen-activated protein kinase inhibitors",
        "mitogen-activated protein kinase kinase inhibitors"
    ],
    "author_names": [
        "Enrico Tiacci",
        "Gianluca Schiavoni",
        "Maria Paola Martelli",
        "Emanuela Boveri",
        "Roberta Pacini",
        "Alessia Tabarrini",
        "Silvia Zibellini",
        "Alessia Santi",
        "Valentina Pettirossi",
        "Elisabetta Fortini",
        "Stefano Ascani",
        "Luca Arcaini",
        "Giorgio Inghirami",
        "Marco Paulli",
        "Brunangelo Falini"
    ],
    "author_dict_list": [
        {
            "author_name": "Enrico Tiacci",
            "author_affiliations": [
                "Institute of Hematology, University of Perugia, Perugia, Italy, "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Gianluca Schiavoni",
            "author_affiliations": [
                "Institute of Hematology, University of Perugia, Perugia, Italy, "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Maria Paola Martelli",
            "author_affiliations": [
                "Institute of Hematology, University of Perugia, Perugia, Italy, "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Emanuela Boveri",
            "author_affiliations": [
                "Department of Human Human Pathology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy, "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Roberta Pacini",
            "author_affiliations": [
                "Institute of Hematology, University of Perugia, Perugia, Italy, "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessia Tabarrini",
            "author_affiliations": [
                "Institute of Hematology, University of Perugia, Perugia, Italy, "
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Silvia Zibellini",
            "author_affiliations": [
                "Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo & University of Pavia, Pavia, Italy, "
            ],
            "author_rank": 7,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Alessia Santi",
            "author_affiliations": [
                "Institute of Hematology, University of Perugia, Perugia, Italy, "
            ],
            "author_rank": 8,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Valentina Pettirossi",
            "author_affiliations": [
                "Institute of Hematology, University of Perugia, Perugia, Italy, "
            ],
            "author_rank": 9,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Elisabetta Fortini",
            "author_affiliations": [
                "Institute of Hematology, University of Perugia, Perugia, Italy, "
            ],
            "author_rank": 10,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Stefano Ascani",
            "author_affiliations": [
                "Institute of Pathology, University of Perugia, Italy, "
            ],
            "author_rank": 11,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Luca Arcaini",
            "author_affiliations": [
                "Department of Hematology Oncology, Fondazione IRCCS Policlinico San Matteo & University of Pavia, Pavia, Italy, "
            ],
            "author_rank": 12,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Giorgio Inghirami",
            "author_affiliations": [
                "Center for Experimental Research and Medical Studies, University of Turin, Turin, Italy, "
            ],
            "author_rank": 13,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Marco Paulli",
            "author_affiliations": [
                "Anatomic pathology section, Department of Molecular medicine, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy"
            ],
            "author_rank": 14,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Brunangelo Falini",
            "author_affiliations": [
                "Institute of Hematology, University of Perugia, Perugia, Italy, "
            ],
            "author_rank": 15,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-24T21:31:36",
    "is_scraped": "1"
}